Skip to main content
About the Institute
  • English
  • Français
  • Español

Breadcrumb

  1. Home
  2. Microbiota 17 - December 2022
  3. Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section
Gastroenterology
Gynecology
Pediatrics
Dermatology

Breadcrumb

  1. Home
  2. Microbiota 17 - December 2022
  3. Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants
Pediatrics

Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants

Baby health
Gastrointestinal

Commented article - Children's section

By Pr. Emmanuel Mas
Gastroenterology and Nutrition Department, Children’s Hospital, Toulouse, France

Gastroenterology
Gynecology
Pediatrics
Dermatology
  • Our publications
    • News
    • Microbiota Mag
    • Thematic folders
    • Overviews - Microbiota Magazine
  • About the Institute
    • Partnerships
    • Press room
  • Congresses
    • Congress calendar
    • Congress reviews
  • Continuing Medical Education
    • Accrediting courses
    • Xpeer App
  • Useful documents
    • Infographics
    • IBS Diagnosis Check List
    About the Institute

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

Lay public section

Find here your dedicated section

Sources

This article is based on scientific information

Sharing is caring

Your colleagues might be interested in this topic. Why not share it?

  • Facebook
  • Twitter
  • LinkedIn
  • Mail

Sections

Microbiota 17_bandeau Mas

About this article

Created 16 January 2023
Updated 22 February 2023

Comment on the article by Asbury et al. (Cell Host Microbe) [1]

Nutrient fortifiers are added to human milk to support the development of verylow- birth-weight infants. At present, bovine-milk-based fortifiers (BMBFs) are predominantly administered, but there is an increasing interest in adopting humanmilk- based fortifiers (HMBFs). Although beneficial for growth, their effects on the gastrointestinal microbiota are unclear. This triple-blind, randomised clinical trial (NCT02137473) tested how nutrient-enriching human milk with HMBFs versus BMBFs affects the gastrointestinal microbiota of infants born <1,250 g during hospitalisation. These results highlight how nutrient fortifiers impact the microbiota of very-low-birth-weight infants during a critical developmental window.

WHAT DO WE ALREADY KNOW ABOUT THIS SUBJECT?

Breast milk (BM) is recognised as the best choice for feeding infants, especially those with a very-low-birth-weight (VLBW), i.e. <1,250 g. In intensive care units, when breastfeeding is impossible, it is recommended using pasteurised human breast milk (PHBM) donated from a breast-milk bank. BM or PHBM often requires enrichment to ensure optimal growth. Bovine milk- based fortifiers (BMBFs) have traditionally been used for enrichment; however, more recently, human-milk-based fortifiers (HMBFs) are also used. While it is well established that VLBW infants have abnormal gut microbiota, it is not known how to improve the composition of this gut microbiota with the nutrients used in VLBW infants.

Clinical studies are needed to determine the impact of these different enrichments on the gut microbiota of VLBW infants.

WHAT ARE THE MAIN INSIGHTS FROM THIS STUDY?

The OptiMom randomised controlled trial included 119 infants with a birth weight <1,250g (56 BMBFs and 63 HMBFs). The median term and birth weight were 880 g and 27.9 weeks, with no differences in any of the parameters between the two groups. HMBF infants had lower microbial diversity (Shannon index) (p <0.005). A predominance of Proteobacteria and Firmicutes was observed in both groups, with a higher relative abundance of Proteobacteria (p = 0.0003) including unclassified Enterobacteriaceae (p = 0.005) and a lower abundance of Firmicutes (p = 0.001) including Clostridium stricto sensu (p = 0.04) in HMBFs compared to BMBFs (Figure 1). Bacterial abundance increased steadily over time in the BMBF group but changed little in the HMBF group (p = 0.03). The relative abundance of Clostridium stricto sensu (p = 0.04) was higher in BMBF infants compared to HMBF infants, and unclassified Enterobacteriaceae were lower (p = 0.005)(Figure 2). After normalising the abundance of taxa, other differences emerged on a genus level with higher concentrations of unclassified Eubacteriaceae (p <0.0001), Streptococcus (p = 0.0002) and Staphylococcus (p = 0.002), and lower concentrations of Clostridium stricto sensu (p = 0.04) in HMBF infants compared to BMBF infants. These changes in bacterial abundance were associated with changes in microbial function. Finally, it was possible to predict the type of fortifier received based on microbial abundance in stools.

The authors were interested in the effects of milk volumes. In both groups, higher volumes of BM for three days were associated with higher alpha diversity but were unrelated to total bacterial density. With higher BM volumes, a higher relative and normalised abundance of Veillonella was observed in both groups, and Streptococcus in the BMBF group. A positive link between BM volumes and Staphylococcus concentrations was observed in the HMBF group, and with unclassified Eubacteriaceae in the BMBF group.

PHBM volumes were only associated with higher diversity in the BMBF group and bacterial density. Similarly, lower relative and standardised abundances of unclassified Eubacteriaceae, Streptococcus and higher abundance of Clostridium stricto sensu were reported in BMBF infants with higher PHBM volumes.

Higher volumes of BMBF were positively related to bacterial diversity and density in the BMBF group but not in the HMBF group. BMBF volumes were positively associated with relative and standardised abundances of Firmicutes and Clostridium stricto sensu, whereas HMBF volumes were positively associated with relative and standardised abundances of Clostridium stricto sensu and negatively associated with Staphylococcus.

infographic

Key point

  • The use of human-milk based fortifiers or bovinemilk based fortifiers in the diet of very-low-birth-weight infants alters differently the bacterial composition of the gut microbiota during the first weeks of life
infographic

WHAT ARE THE CONSEQUENCES IN PRACTICE?

This study shows the importance of understanding the impact of the different nutrients used in the gut microbiota of VLBW infants to achieve a beneficial effect on their shortand long-term health.

Conclusion

This study showed that nutritional fortifiers alter the development of the gut microbiota in very-low-birthweight infants. It also showed that associations exist between amounts of enteral nutrition components in these children, BM, PHBM and bacterial communities.

Sources

1. Asbury MR, Shama S, Sa JY, et al. ; OptiMoM Feeding Group. Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants. Cell Host Microbe 2022; 30: 1328-39.e5.

Tags
breast milk Baby Health Gut microbiota Gastrointestinal system

en_view en_sources

    Focus
    Microbiota 17 - December 2022
    • Overview
      • Microbial colonization as a determinant factor for health during the first 1000 days of life
    • Commented article
      • Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signalling in mice
      • Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants
    • Focus on
      • The Gut-Brain axis
    • Congress review
      • Highlights from the UEGW
    • Press review
      • Gut Microbiota #17
      • Skin Microbiota #17
    • Expert opinion
      • Impact of beer and non alcoholic consumption on the gut microbiota
    Created 16 January 2023
    Updated 22 February 2023

    About this article

    To know more about this topic.

    Main topic

    Baby health

    Medical practice

    Gastrointestinal

    Content type

    Commented article
    Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signalling in mice
    The Gut-Brain axis
    Focus

    Microbiota 17 - December 2022

    Overview

    Microbial colonization as a determinant factor for health during the first 1000 days of life

    Commented article

    Histamine production by the gut microbiota induces visceral hyperalgesia through histamine 4 receptor signalling in mice Human milk nutrient fortifiers alter the developing gastrointestinal microbiota of very-low-birth-weight infants

    Focus on

    The Gut-Brain axis

    Congress review

    Highlights from the UEGW

    Press review

    Gut Microbiota #17 Skin Microbiota #17

    Expert opinion

    Impact of beer and non alcoholic consumption on the gut microbiota

    Continue reading

    News
    16.11.2022

    Alcohol use disorders: in microbiota veritas?

    Read the article

    Infographics to share with your patients!

    Download original graphic material to explain to your patients the role of the microbiota in their da...

    Find out more

    Everything you need to know about Irritable Bowel Syndrome (IBS)

    Accrediting training, infographics, expert’s video,...

    Find out more
    Binge drinking : une dysbiose intestinale liée à l’alcool favoriserait l’addiction
    24.03.2023

    Binge drinking: alcohol-related gut dysbiosis may contribute to addiction

    Read the article
    20.03.2023

    The role of Bifidobacteria in irritable bowel syndrome (IBS)

    Read the article
    09.03.2023

    Each subtype of Irritable Bowel Syndrome (IBS) has its own dysbiosis

    Read the article

    Xpeer course: Detection, Prevention and Treatment of Gut Microbiome Dysbiosis

    Find out more

    Your IBS Diagnosis Check List

    How many patients suffering from gut disorder do you see per week? How many are diagnosed with Irrita...

    Find out more
    What's worth reading about microbiota
    Follow us on Twitter
    Read our thematic folder
    The Janus face of Antibiotics: Life Savers & Microbiota Disrupters
    Microbiota 17 EN
    Check out our latest magazine
    The first 1000 days of life
    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section
    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology
    • English
    • Français
    • Español

    Browse the site

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    Lay public section

    Find here your dedicated section

    Redirection

    You are about to be redirected and leave our website

    • Be redirected
    • Stay on the Biocodex Microbiota Institute's website

    Stay with us !

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    Explore

    Obesity: Is a bacterial fatty acid involved?
    15.05.2023

    Obesity: Is a bacterial fatty acid involved?

    Read the article
    Photo: Endométriose : une clé de sa progression au sein du microbiote intestinal
    09.05.2023

    Endometriosis: A key to its progression in the gut microbiota?

    Read the article
    Photo: Atténuer la dénutrition avec des biotiques ?
    26.04.2023

    Mitigating malnutrition with biotics?

    Read the article

    Stay updated

    Join the Microbiota Community of HCPs and researchers and receive “Microbiota Digest” and "Microbiota Mag" to stay up to date on the latest news about microbiota.

    * Mandatory Fields

    BMI 20-35

    • Our publications
      • News
      • Microbiota Mag
      • Thematic folders
      • Overviews - Microbiota Magazine
    • About the Institute
      • Partnerships
      • Press room
    • Congresses
      • Congress calendar
      • Congress reviews
    • Continuing Medical Education
      • Accrediting courses
      • Xpeer App
    • Useful documents
      • Infographics
      • IBS Diagnosis Check List
      About the Institute

      Join the microbiota community

      • Facebook
      • Twitter
      • LinkedIn
      • YouTube

    Lay public section

    Find here your dedicated section

    Discover

    Gastroenterology
    Gynecology
    Pediatrics
    Dermatology

    Lay public section

    Find here your dedicated section

    Join the microbiota community

    • Facebook
    • Twitter
    • LinkedIn
    • YouTube

    © 2022 Biocodex. All rights reserved.

    • Cookies Policy
    • Data protection policy
    • GTU
    • Sitemap
    • Cookies settings
    Biocodex logo